

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | type B pancreatic cell proliferation (GO:0044342) | 5.91667720 |
| 2 | cell migration involved in heart development (GO:0060973) | 5.44379099 |
| 3 | protein heterotrimerization (GO:0070208) | 5.10483387 |
| 4 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 5.05555337 |
| 5 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.88382883 |
| 6 | collagen fibril organization (GO:0030199) | 4.44154330 |
| 7 | negative regulation of smooth muscle cell migration (GO:0014912) | 4.35816106 |
| 8 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 4.10950217 |
| 9 | kidney mesenchyme development (GO:0072074) | 4.05662997 |
| 10 | tooth mineralization (GO:0034505) | 3.98483738 |
| 11 | keratan sulfate catabolic process (GO:0042340) | 3.88935903 |
| 12 | carnitine shuttle (GO:0006853) | 3.88360300 |
| 13 | bone trabecula formation (GO:0060346) | 3.86572508 |
| 14 | dermatan sulfate metabolic process (GO:0030205) | 3.84954610 |
| 15 | low-density lipoprotein particle clearance (GO:0034383) | 3.84346658 |
| 16 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.80988616 |
| 17 | dermatan sulfate biosynthetic process (GO:0030208) | 3.80746791 |
| 18 | positive regulation of fatty acid oxidation (GO:0046321) | 3.79367455 |
| 19 | fatty acid transmembrane transport (GO:1902001) | 3.79149861 |
| 20 | extracellular matrix assembly (GO:0085029) | 3.78287790 |
| 21 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.77718746 |
| 22 | endocardial cushion development (GO:0003197) | 3.69613813 |
| 23 | regulation of sequestering of triglyceride (GO:0010889) | 3.54302160 |
| 24 | barbed-end actin filament capping (GO:0051016) | 3.53663869 |
| 25 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.44509913 |
| 26 | extracellular fibril organization (GO:0043206) | 3.42058546 |
| 27 | adhesion of symbiont to host cell (GO:0044650) | 3.38987413 |
| 28 | virion attachment to host cell (GO:0019062) | 3.38987413 |
| 29 | smooth muscle tissue development (GO:0048745) | 3.37380085 |
| 30 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.35854130 |
| 31 | valine metabolic process (GO:0006573) | 3.29850734 |
| 32 | cellular response to vitamin (GO:0071295) | 3.22744207 |
| 33 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.22327292 |
| 34 | fatty acid beta-oxidation (GO:0006635) | 3.21780928 |
| 35 | cell proliferation involved in metanephros development (GO:0072203) | 3.21718472 |
| 36 | collagen metabolic process (GO:0032963) | 3.20995988 |
| 37 | middle ear morphogenesis (GO:0042474) | 3.18725747 |
| 38 | multicellular organismal metabolic process (GO:0044236) | 3.17119203 |
| 39 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.16713326 |
| 40 | regulation of fatty acid oxidation (GO:0046320) | 3.16574285 |
| 41 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.11191766 |
| 42 | biotin metabolic process (GO:0006768) | 3.10352360 |
| 43 | apoptotic cell clearance (GO:0043277) | 3.08805513 |
| 44 | collagen catabolic process (GO:0030574) | 3.08194016 |
| 45 | cardiac myofibril assembly (GO:0055003) | 3.05457697 |
| 46 | adhesion of symbiont to host (GO:0044406) | 3.04264669 |
| 47 | venous blood vessel morphogenesis (GO:0048845) | 3.04156481 |
| 48 | chondroitin sulfate catabolic process (GO:0030207) | 3.03623330 |
| 49 | multicellular organismal catabolic process (GO:0044243) | 3.02822337 |
| 50 | axon extension involved in axon guidance (GO:0048846) | 3.01771851 |
| 51 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.01771851 |
| 52 | carnitine transmembrane transport (GO:1902603) | 3.01715258 |
| 53 | plasma membrane repair (GO:0001778) | 3.01235351 |
| 54 | amino-acid betaine transport (GO:0015838) | 3.00060840 |
| 55 | carnitine transport (GO:0015879) | 3.00060840 |
| 56 | protein localization to cell surface (GO:0034394) | 2.98856458 |
| 57 | extracellular matrix organization (GO:0030198) | 2.97882591 |
| 58 | extracellular structure organization (GO:0043062) | 2.96799571 |
| 59 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.96036047 |
| 60 | stress fiber assembly (GO:0043149) | 2.95652779 |
| 61 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.95134421 |
| 62 | basement membrane organization (GO:0071711) | 2.94535106 |
| 63 | fibril organization (GO:0097435) | 2.94116144 |
| 64 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.89962362 |
| 65 | hyaluronan catabolic process (GO:0030214) | 2.88795294 |
| 66 | glomerular basement membrane development (GO:0032836) | 2.87529470 |
| 67 | endodermal cell differentiation (GO:0035987) | 2.87168345 |
| 68 | regulation of extracellular matrix disassembly (GO:0010715) | 2.84647077 |
| 69 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.84263224 |
| 70 | sarcomere organization (GO:0045214) | 2.83333016 |
| 71 | regulation of plasminogen activation (GO:0010755) | 2.83020304 |
| 72 | white fat cell differentiation (GO:0050872) | 2.82226633 |
| 73 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.81185460 |
| 74 | negative regulation of BMP signaling pathway (GO:0030514) | 2.81101549 |
| 75 | glomerular filtration (GO:0003094) | 2.80763041 |
| 76 | skin morphogenesis (GO:0043589) | 2.80091135 |
| 77 | brown fat cell differentiation (GO:0050873) | 2.78970409 |
| 78 | fatty acid oxidation (GO:0019395) | 2.78785925 |
| 79 | regulation of skeletal muscle contraction (GO:0014819) | 2.77838338 |
| 80 | positive regulation of p38MAPK cascade (GO:1900745) | 2.77708723 |
| 81 | positive regulation of fibroblast migration (GO:0010763) | 2.77600905 |
| 82 | regulation of p38MAPK cascade (GO:1900744) | 2.75163506 |
| 83 | blood vessel maturation (GO:0001955) | 2.73749877 |
| 84 | extracellular negative regulation of signal transduction (GO:1900116) | 2.73539244 |
| 85 | extracellular regulation of signal transduction (GO:1900115) | 2.73539244 |
| 86 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.73171539 |
| 87 | regulation of smooth muscle cell migration (GO:0014910) | 2.72870015 |
| 88 | lipid oxidation (GO:0034440) | 2.72261454 |
| 89 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.68739653 |
| 90 | glycosaminoglycan catabolic process (GO:0006027) | 2.67955291 |
| 91 | outer ear morphogenesis (GO:0042473) | 2.67152108 |
| 92 | fatty acid catabolic process (GO:0009062) | 2.66972516 |
| 93 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.65574987 |
| 94 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.65361786 |
| 95 | negative regulation of fatty acid transport (GO:2000192) | 2.64772176 |
| 96 | endothelial cell morphogenesis (GO:0001886) | 2.64756179 |
| 97 | complement activation, alternative pathway (GO:0006957) | 2.64415334 |
| 98 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.63580906 |
| 99 | negative regulation of heart growth (GO:0061117) | 2.63580906 |
| 100 | epithelial cell-cell adhesion (GO:0090136) | 2.63288701 |
| 101 | lipid particle organization (GO:0034389) | 2.63158834 |
| 102 | myofibril assembly (GO:0030239) | 2.62524608 |
| 103 | trabecula formation (GO:0060343) | 2.62424800 |
| 104 | extracellular matrix disassembly (GO:0022617) | 2.61627518 |
| 105 | positive regulation of glycogen metabolic process (GO:0070875) | 2.60859315 |
| 106 | chondrocyte proliferation (GO:0035988) | 2.60727651 |
| 107 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 2.59725318 |
| 108 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.59613671 |
| 109 | cell proliferation involved in kidney development (GO:0072111) | 2.59230843 |
| 110 | 2-oxoglutarate metabolic process (GO:0006103) | 2.57246344 |
| 111 | regulation of tight junction assembly (GO:2000810) | 2.57053718 |
| 112 | pericardium development (GO:0060039) | 2.56680650 |
| 113 | growth hormone receptor signaling pathway (GO:0060396) | 2.56289532 |
| 114 | renal filtration (GO:0097205) | 2.56261637 |
| 115 | triglyceride catabolic process (GO:0019433) | 2.54683539 |
| 116 | phagocytosis, recognition (GO:0006910) | 2.53913409 |
| 117 | artery morphogenesis (GO:0048844) | 2.52403845 |
| 118 | cGMP-mediated signaling (GO:0019934) | 2.51753736 |
| 119 | positive regulation of gastrulation (GO:2000543) | 2.51707643 |
| 120 | tricarboxylic acid metabolic process (GO:0072350) | 2.51663840 |
| 121 | regulation of collagen metabolic process (GO:0010712) | 2.51432803 |
| 122 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.51160021 |
| 123 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.51160021 |
| 124 | embryo implantation (GO:0007566) | 2.49228019 |
| 125 | lysine metabolic process (GO:0006553) | 2.48696063 |
| 126 | lysine catabolic process (GO:0006554) | 2.48696063 |
| 127 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.46595003 |
| 128 | muscle cell migration (GO:0014812) | 2.46206173 |
| 129 | regulation of phospholipase A2 activity (GO:0032429) | 2.46152279 |
| 130 | positive regulation of mesenchymal cell proliferation (GO:0002053) | 2.45746324 |
| 131 | cell-substrate junction assembly (GO:0007044) | 2.44985174 |
| 132 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.44797017 |
| 133 | intracellular lipid transport (GO:0032365) | 2.44724007 |
| 134 | oxaloacetate metabolic process (GO:0006107) | 2.44650274 |
| 135 | quaternary ammonium group transport (GO:0015697) | 2.43880441 |
| 136 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.43812529 |
| 137 | epoxygenase P450 pathway (GO:0019373) | 2.43755406 |
| 138 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.43184289 |
| 139 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.42978856 |
| 140 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 2.42740344 |
| 141 | branched-chain amino acid metabolic process (GO:0009081) | 2.42169137 |
| 142 | fibroblast migration (GO:0010761) | 2.40888938 |
| 143 | negative regulation of complement activation (GO:0045916) | 2.40581425 |
| 144 | aminoglycan catabolic process (GO:0006026) | 2.39880580 |
| 145 | tricarboxylic acid cycle (GO:0006099) | 2.39699596 |
| 146 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.39439514 |
| 147 | metanephric mesenchyme development (GO:0072075) | 2.39385759 |
| 148 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.39199161 |
| 149 | lung vasculature development (GO:0060426) | 2.38476413 |
| 150 | negative regulation of cartilage development (GO:0061037) | 2.38156467 |
| 151 | endocrine hormone secretion (GO:0060986) | 2.38037406 |
| 152 | homocysteine metabolic process (GO:0050667) | 2.37360063 |
| 153 | protein hydroxylation (GO:0018126) | 2.36606677 |
| 154 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.36368656 |
| 155 | positive regulation of lipid catabolic process (GO:0050996) | 2.35520009 |
| 156 | NADH metabolic process (GO:0006734) | 2.33817224 |
| 157 | muscle filament sliding (GO:0030049) | 2.33498032 |
| 158 | actin-myosin filament sliding (GO:0033275) | 2.33498032 |
| 159 | cellular response to nutrient (GO:0031670) | 2.33493492 |
| 160 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.31959148 |
| 161 | acylglycerol catabolic process (GO:0046464) | 2.31142860 |
| 162 | neutral lipid catabolic process (GO:0046461) | 2.31142860 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.50367353 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.92299892 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.30844893 |
| 4 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.10836649 |
| 5 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.99897772 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.86325649 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.74781143 |
| 8 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.52850804 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.46444212 |
| 10 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.34553078 |
| 11 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.27784184 |
| 12 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.21957003 |
| 13 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.13666430 |
| 14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.01691495 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.00275610 |
| 16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.98575281 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.95505039 |
| 18 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.90423458 |
| 19 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.83793025 |
| 20 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.75844427 |
| 21 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.70284898 |
| 22 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.70284898 |
| 23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.69827881 |
| 24 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.56329833 |
| 25 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.53266230 |
| 26 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.49885931 |
| 27 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.49885931 |
| 28 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.49781340 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.46889647 |
| 30 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.43259149 |
| 31 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.42914900 |
| 32 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.42822098 |
| 33 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.42512373 |
| 34 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.40354552 |
| 35 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.40200564 |
| 36 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.39782395 |
| 37 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.39327258 |
| 38 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.39127938 |
| 39 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.37368625 |
| 40 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.36832656 |
| 41 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.34352228 |
| 42 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.34352228 |
| 43 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.33150453 |
| 44 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.32381614 |
| 45 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32308124 |
| 46 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.30332626 |
| 47 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.27521088 |
| 48 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25786934 |
| 49 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.25168433 |
| 50 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.23692645 |
| 51 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.23260533 |
| 52 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.22426230 |
| 53 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.22139828 |
| 54 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.20889882 |
| 55 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.20809141 |
| 56 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.19492163 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18585326 |
| 58 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.18355065 |
| 59 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.18330420 |
| 60 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16289329 |
| 61 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.15026133 |
| 62 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.12621270 |
| 63 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.12096563 |
| 64 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.12015104 |
| 65 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.10904843 |
| 66 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09017113 |
| 67 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.07544253 |
| 68 | GATA1_22025678_ChIP-Seq_K562_Human | 1.06845636 |
| 69 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.06788992 |
| 70 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.05850880 |
| 71 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.05633005 |
| 72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.04728228 |
| 73 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.03529846 |
| 74 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01268336 |
| 75 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.99834978 |
| 76 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99307866 |
| 77 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.98018563 |
| 78 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97706549 |
| 79 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.97676810 |
| 80 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.95866264 |
| 81 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.95843959 |
| 82 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95584668 |
| 83 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.94892506 |
| 84 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.94856073 |
| 85 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.94606389 |
| 86 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.94568337 |
| 87 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.94370624 |
| 88 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.94116847 |
| 89 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.93357917 |
| 90 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.93170611 |
| 91 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92652807 |
| 92 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92236011 |
| 93 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.91817230 |
| 94 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.90720620 |
| 95 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.90516142 |
| 96 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90303572 |
| 97 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.90134485 |
| 98 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89341505 |
| 99 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89095420 |
| 100 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.88594835 |
| 101 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.88368838 |
| 102 | KDM2B_26808549_Chip-Seq_K562_Human | 0.87950541 |
| 103 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.87660306 |
| 104 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87164224 |
| 105 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.87139156 |
| 106 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.87055325 |
| 107 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87037761 |
| 108 | TP53_16413492_ChIP-PET_HCT116_Human | 0.86680389 |
| 109 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.86531984 |
| 110 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.86521321 |
| 111 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86137304 |
| 112 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.85295466 |
| 113 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.85266393 |
| 114 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.84711413 |
| 115 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.83894016 |
| 116 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.83820324 |
| 117 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.83775914 |
| 118 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.83597054 |
| 119 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.82751733 |
| 120 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.82488593 |
| 121 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.82356157 |
| 122 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.82282649 |
| 123 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.81604822 |
| 124 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.80730007 |
| 125 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.80680636 |
| 126 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.80090623 |
| 127 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.79793080 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 7.50984522 |
| 2 | MP0005275_abnormal_skin_tensile | 5.39905848 |
| 3 | MP0005503_abnormal_tendon_morphology | 4.91555119 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 4.05032193 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.35722663 |
| 6 | MP0005670_abnormal_white_adipose | 3.19841328 |
| 7 | MP0001958_emphysema | 2.88577753 |
| 8 | MP0003279_aneurysm | 2.59438654 |
| 9 | MP0000751_myopathy | 2.48314031 |
| 10 | MP0005257_abnormal_intraocular_pressure | 2.43122772 |
| 11 | MP0004272_abnormal_basement_membrane | 2.25709670 |
| 12 | MP0005666_abnormal_adipose_tissue | 2.18861881 |
| 13 | MP0000013_abnormal_adipose_tissue | 2.13881296 |
| 14 | MP0004130_abnormal_muscle_cell | 2.10968595 |
| 15 | MP0002108_abnormal_muscle_morphology | 1.96595869 |
| 16 | MP0005375_adipose_tissue_phenotype | 1.83557011 |
| 17 | MP0002060_abnormal_skin_morphology | 1.77385127 |
| 18 | MP0006054_spinal_hemorrhage | 1.75679764 |
| 19 | MP0004185_abnormal_adipocyte_glucose | 1.70848074 |
| 20 | MP0000003_abnormal_adipose_tissue | 1.61527898 |
| 21 | MP0005508_abnormal_skeleton_morphology | 1.60199987 |
| 22 | MP0004084_abnormal_cardiac_muscle | 1.59743107 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 1.59298646 |
| 24 | MP0002295_abnormal_pulmonary_circulatio | 1.58795930 |
| 25 | MP0000749_muscle_degeneration | 1.56799083 |
| 26 | MP0003566_abnormal_cell_adhesion | 1.52542496 |
| 27 | MP0003646_muscle_fatigue | 1.51750099 |
| 28 | MP0009384_cardiac_valve_regurgitation | 1.50803451 |
| 29 | MP0005360_urolithiasis | 1.45646489 |
| 30 | MP0000750_abnormal_muscle_regeneration | 1.45408356 |
| 31 | MP0003091_abnormal_cell_migration | 1.42613075 |
| 32 | MP0005330_cardiomyopathy | 1.41498649 |
| 33 | MP0003045_fibrosis | 1.36950167 |
| 34 | MP0003252_abnormal_bile_duct | 1.34933441 |
| 35 | MP0004215_abnormal_myocardial_fiber | 1.34832570 |
| 36 | MP0010368_abnormal_lymphatic_system | 1.32575542 |
| 37 | MP0004087_abnormal_muscle_fiber | 1.30792232 |
| 38 | MP0006138_congestive_heart_failure | 1.30487118 |
| 39 | MP0004036_abnormal_muscle_relaxation | 1.25318577 |
| 40 | MP0004858_abnormal_nervous_system | 1.23282025 |
| 41 | MP0002254_reproductive_system_inflammat | 1.21842136 |
| 42 | MP0005620_abnormal_muscle_contractility | 1.21062023 |
| 43 | MP0008775_abnormal_heart_ventricle | 1.20593990 |
| 44 | MP0000049_abnormal_middle_ear | 1.16705548 |
| 45 | MP0002971_abnormal_brown_adipose | 1.15506377 |
| 46 | MP0010329_abnormal_lipoprotein_level | 1.15253063 |
| 47 | MP0000759_abnormal_skeletal_muscle | 1.14332595 |
| 48 | MP0001348_abnormal_lacrimal_gland | 1.12386135 |
| 49 | MP0002972_abnormal_cardiac_muscle | 1.12025937 |
| 50 | MP0010386_abnormal_urinary_bladder | 1.11927121 |
| 51 | MP0001299_abnormal_eye_distance/ | 1.11385963 |
| 52 | MP0005369_muscle_phenotype | 1.10811859 |
| 53 | MP0001544_abnormal_cardiovascular_syste | 1.09965672 |
| 54 | MP0005385_cardiovascular_system_phenoty | 1.09965672 |
| 55 | MP0005164_abnormal_response_to | 1.09635346 |
| 56 | MP0005623_abnormal_meninges_morphology | 1.08837522 |
| 57 | MP0002139_abnormal_hepatobiliary_system | 1.08592169 |
| 58 | MP0009115_abnormal_fat_cell | 1.06914860 |
| 59 | MP0002896_abnormal_bone_mineralization | 1.04074232 |
| 60 | MP0003828_pulmonary_edema | 1.03548121 |
| 61 | MP0003191_abnormal_cellular_cholesterol | 1.02739404 |
| 62 | MP0000534_abnormal_ureter_morphology | 1.01473249 |
| 63 | MP0005023_abnormal_wound_healing | 1.00129459 |
| 64 | MP0003942_abnormal_urinary_system | 0.97637319 |
| 65 | MP0002933_joint_inflammation | 0.95150084 |
| 66 | MP0010030_abnormal_orbit_morphology | 0.94826159 |
| 67 | MP0005365_abnormal_bile_salt | 0.94721385 |
| 68 | MP0002249_abnormal_larynx_morphology | 0.94283470 |
| 69 | MP0002168_other_aberrant_phenotype | 0.94249929 |
| 70 | MP0002877_abnormal_melanocyte_morpholog | 0.92152759 |
| 71 | MP0005334_abnormal_fat_pad | 0.91989987 |
| 72 | MP0002106_abnormal_muscle_physiology | 0.91556956 |
| 73 | MP0003385_abnormal_body_wall | 0.89897966 |
| 74 | MP0003283_abnormal_digestive_organ | 0.89437840 |
| 75 | MP0001849_ear_inflammation | 0.87951873 |
| 76 | MP0000163_abnormal_cartilage_morphology | 0.87664967 |
| 77 | MP0003011_delayed_dark_adaptation | 0.87413445 |
| 78 | MP0005390_skeleton_phenotype | 0.86855530 |
| 79 | MP0010630_abnormal_cardiac_muscle | 0.85229559 |
| 80 | MP0000767_abnormal_smooth_muscle | 0.85097527 |
| 81 | MP0002876_abnormal_thyroid_physiology | 0.84433955 |
| 82 | MP0002118_abnormal_lipid_homeostasis | 0.84430373 |
| 83 | MP0000428_abnormal_craniofacial_morphol | 0.83273796 |
| 84 | MP0000747_muscle_weakness | 0.83012340 |
| 85 | MP0004145_abnormal_muscle_electrophysio | 0.82426794 |
| 86 | MP0004883_abnormal_blood_vessel | 0.81779998 |
| 87 | MP0004484_altered_response_of | 0.81206326 |
| 88 | MP0000343_altered_response_to | 0.81196907 |
| 89 | MP0002269_muscular_atrophy | 0.80984630 |
| 90 | MP0005595_abnormal_vascular_smooth | 0.80399362 |
| 91 | MP0001879_abnormal_lymphatic_vessel | 0.79415541 |
| 92 | MP0002998_abnormal_bone_remodeling | 0.79174330 |
| 93 | MP0004134_abnormal_chest_morphology | 0.78920729 |
| 94 | MP0000462_abnormal_digestive_system | 0.77805495 |
| 95 | MP0001243_abnormal_dermal_layer | 0.77415597 |
| 96 | MP0001756_abnormal_urination | 0.74897848 |
| 97 | MP0000230_abnormal_systemic_arterial | 0.74397692 |
| 98 | MP0009250_abnormal_appendicular_skeleto | 0.73957707 |
| 99 | MP0002113_abnormal_skeleton_development | 0.73491823 |
| 100 | MP0002115_abnormal_skeleton_extremities | 0.72796781 |
| 101 | MP0002970_abnormal_white_adipose | 0.71428953 |
| 102 | MP0000538_abnormal_urinary_bladder | 0.70966114 |
| 103 | MP0003115_abnormal_respiratory_system | 0.70584170 |
| 104 | MP0005058_abnormal_lysosome_morphology | 0.70379772 |
| 105 | MP0002127_abnormal_cardiovascular_syste | 0.70204771 |
| 106 | MP0001542_abnormal_bone_strength | 0.69713791 |
| 107 | MP0001661_extended_life_span | 0.69687868 |
| 108 | MP0004043_abnormal_pH_regulation | 0.69108419 |
| 109 | MP0000733_abnormal_muscle_development | 0.68935688 |
| 110 | MP0003795_abnormal_bone_structure | 0.68674413 |
| 111 | MP0001614_abnormal_blood_vessel | 0.68497356 |
| 112 | MP0005388_respiratory_system_phenotype | 0.68489460 |
| 113 | MP0002133_abnormal_respiratory_system | 0.68489460 |
| 114 | MP0009643_abnormal_urine_homeostasis | 0.67112672 |
| 115 | MP0009840_abnormal_foam_cell | 0.66640276 |
| 116 | MP0002128_abnormal_blood_circulation | 0.66149881 |
| 117 | MP0003300_gastrointestinal_ulcer | 0.65776545 |
| 118 | MP0000681_abnormal_thyroid_gland | 0.65579601 |
| 119 | MP0001175_abnormal_lung_morphology | 0.64937592 |
| 120 | MP0002078_abnormal_glucose_homeostasis | 0.64703463 |
| 121 | MP0003941_abnormal_skin_development | 0.64259094 |
| 122 | MP0005171_absent_coat_pigmentation | 0.63836851 |
| 123 | MP0002932_abnormal_joint_morphology | 0.62621756 |
| 124 | MP0005332_abnormal_amino_acid | 0.62331793 |
| 125 | MP0003950_abnormal_plasma_membrane | 0.61779904 |
| 126 | MP0000249_abnormal_blood_vessel | 0.61498697 |
| 127 | MP0001533_abnormal_skeleton_physiology | 0.61453787 |
| 128 | MP0003724_increased_susceptibility_to | 0.61179123 |
| 129 | MP0003448_altered_tumor_morphology | 0.60368096 |
| 130 | MP0005448_abnormal_energy_balance | 0.60266205 |
| 131 | MP0004510_myositis | 0.58954343 |
| 132 | MP0002116_abnormal_craniofacial_bone | 0.58261773 |
| 133 | MP0000762_abnormal_tongue_morphology | 0.53066162 |
| 134 | MP0000432_abnormal_head_morphology | 0.52957557 |
| 135 | MP0005197_abnormal_uvea_morphology | 0.52738492 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 7.15181649 |
| 2 | Premature rupture of membranes (HP:0001788) | 6.40838334 |
| 3 | Broad metatarsal (HP:0001783) | 5.26675375 |
| 4 | Increased connective tissue (HP:0009025) | 4.56341111 |
| 5 | Ankle contracture (HP:0006466) | 4.32809894 |
| 6 | Aortic dissection (HP:0002647) | 4.25875763 |
| 7 | Muscle fiber splitting (HP:0003555) | 3.97833958 |
| 8 | Type 1 muscle fiber predominance (HP:0003803) | 3.91312877 |
| 9 | Arterial tortuosity (HP:0005116) | 3.89701775 |
| 10 | Soft skin (HP:0000977) | 3.88406159 |
| 11 | Aortic aneurysm (HP:0004942) | 3.87192002 |
| 12 | Shallow orbits (HP:0000586) | 3.87051516 |
| 13 | Right ventricular cardiomyopathy (HP:0011663) | 3.77811465 |
| 14 | Cerebral aneurysm (HP:0004944) | 3.62388734 |
| 15 | Bladder diverticulum (HP:0000015) | 3.53662459 |
| 16 | Atrophic scars (HP:0001075) | 3.47264209 |
| 17 | Aortic regurgitation (HP:0001659) | 3.30078509 |
| 18 | Fragile skin (HP:0001030) | 3.23733837 |
| 19 | Cervical subluxation (HP:0003308) | 3.15729164 |
| 20 | Peritonitis (HP:0002586) | 3.12404467 |
| 21 | Dilatation of the ascending aorta (HP:0005111) | 3.11917020 |
| 22 | Spinal rigidity (HP:0003306) | 3.10476726 |
| 23 | Follicular hyperkeratosis (HP:0007502) | 3.08504020 |
| 24 | Increased variability in muscle fiber diameter (HP:0003557) | 3.08000570 |
| 25 | Mitral valve prolapse (HP:0001634) | 2.92398578 |
| 26 | Wrist flexion contracture (HP:0001239) | 2.89455143 |
| 27 | Vertebral compression fractures (HP:0002953) | 2.88151560 |
| 28 | Aortic valve stenosis (HP:0001650) | 2.84502017 |
| 29 | Lipoatrophy (HP:0100578) | 2.82590382 |
| 30 | Blue sclerae (HP:0000592) | 2.80066737 |
| 31 | Sudden death (HP:0001699) | 2.77108858 |
| 32 | Aneurysm (HP:0002617) | 2.75676420 |
| 33 | Ventricular tachycardia (HP:0004756) | 2.72651109 |
| 34 | Hyporeflexia of lower limbs (HP:0002600) | 2.69918650 |
| 35 | Myoglobinuria (HP:0002913) | 2.67436451 |
| 36 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.65357960 |
| 37 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.64905664 |
| 38 | Hyperextensible skin (HP:0000974) | 2.63269961 |
| 39 | Coronal craniosynostosis (HP:0004440) | 2.62950969 |
| 40 | Joint stiffness (HP:0001387) | 2.62017049 |
| 41 | Round ear (HP:0100830) | 2.59840619 |
| 42 | Hypoventilation (HP:0002791) | 2.54435490 |
| 43 | Asymmetric septal hypertrophy (HP:0001670) | 2.47631823 |
| 44 | Oligomenorrhea (HP:0000876) | 2.46210261 |
| 45 | Abnormality of proline metabolism (HP:0010907) | 2.44767599 |
| 46 | Hydroxyprolinuria (HP:0003080) | 2.44767599 |
| 47 | Genu recurvatum (HP:0002816) | 2.43886684 |
| 48 | Ectopia lentis (HP:0001083) | 2.41106590 |
| 49 | Calf muscle hypertrophy (HP:0008981) | 2.37490617 |
| 50 | Thin bony cortex (HP:0002753) | 2.36790548 |
| 51 | Difficulty running (HP:0009046) | 2.35805128 |
| 52 | Exercise-induced myalgia (HP:0003738) | 2.35741216 |
| 53 | Abnormality of the calf musculature (HP:0001430) | 2.33125287 |
| 54 | Nonimmune hydrops fetalis (HP:0001790) | 2.33003908 |
| 55 | Hypoglycemic coma (HP:0001325) | 2.31960980 |
| 56 | Wormian bones (HP:0002645) | 2.31821671 |
| 57 | Mild short stature (HP:0003502) | 2.31122773 |
| 58 | Emphysema (HP:0002097) | 2.29659769 |
| 59 | Slender build (HP:0001533) | 2.28698329 |
| 60 | Abnormality of dentin (HP:0010299) | 2.25427948 |
| 61 | Abnormality of complement system (HP:0005339) | 2.24934686 |
| 62 | Striae distensae (HP:0001065) | 2.24455665 |
| 63 | Neonatal short-limb short stature (HP:0008921) | 2.24229869 |
| 64 | Complement deficiency (HP:0004431) | 2.22872912 |
| 65 | Atrial fibrillation (HP:0005110) | 2.21499620 |
| 66 | Redundant skin (HP:0001582) | 2.20065171 |
| 67 | Joint laxity (HP:0001388) | 2.19400537 |
| 68 | Vascular tortuosity (HP:0004948) | 2.19320086 |
| 69 | Abnormal delivery (HP:0001787) | 2.17957345 |
| 70 | Ketoacidosis (HP:0001993) | 2.17103534 |
| 71 | Hyperglycinuria (HP:0003108) | 2.16859092 |
| 72 | Long toe (HP:0010511) | 2.16338471 |
| 73 | Ovoid vertebral bodies (HP:0003300) | 2.14720750 |
| 74 | Acanthosis nigricans (HP:0000956) | 2.14637027 |
| 75 | Bell-shaped thorax (HP:0001591) | 2.14429874 |
| 76 | Persistence of primary teeth (HP:0006335) | 2.14404900 |
| 77 | Osteolytic defects of the hand bones (HP:0009699) | 2.13934106 |
| 78 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.13934106 |
| 79 | Skin nodule (HP:0200036) | 2.13068720 |
| 80 | Bowel diverticulosis (HP:0005222) | 2.09904509 |
| 81 | Rectal prolapse (HP:0002035) | 2.09695563 |
| 82 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.07777063 |
| 83 | Systemic lupus erythematosus (HP:0002725) | 2.06865907 |
| 84 | Overgrowth (HP:0001548) | 2.06510662 |
| 85 | Mitral stenosis (HP:0001718) | 2.06170071 |
| 86 | Wide anterior fontanel (HP:0000260) | 2.04135031 |
| 87 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.03218850 |
| 88 | Biconcave vertebral bodies (HP:0004586) | 2.01890444 |
| 89 | Infantile muscular hypotonia (HP:0008947) | 2.00305662 |
| 90 | Exercise-induced muscle cramps (HP:0003710) | 1.98830976 |
| 91 | Primary atrial arrhythmia (HP:0001692) | 1.98814326 |
| 92 | Hip contracture (HP:0003273) | 1.97581496 |
| 93 | Generalized aminoaciduria (HP:0002909) | 1.93522405 |
| 94 | Mesomelia (HP:0003027) | 1.93341086 |
| 95 | Camptodactyly of toe (HP:0001836) | 1.92988965 |
| 96 | Turricephaly (HP:0000262) | 1.92730498 |
| 97 | Venous abnormality (HP:0002624) | 1.91873213 |
| 98 | Lymphangioma (HP:0100764) | 1.89938579 |
| 99 | Ulnar bowing (HP:0003031) | 1.89933477 |
| 100 | Supraventricular arrhythmia (HP:0005115) | 1.89465424 |
| 101 | Breech presentation (HP:0001623) | 1.89275291 |
| 102 | Delayed cranial suture closure (HP:0000270) | 1.89197959 |
| 103 | Dilated cardiomyopathy (HP:0001644) | 1.88154215 |
| 104 | Abnormality of the acetabulum (HP:0003170) | 1.87773571 |
| 105 | Ketosis (HP:0001946) | 1.87286496 |
| 106 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.86867621 |
| 107 | Broad ribs (HP:0000885) | 1.85560783 |
| 108 | Gingival overgrowth (HP:0000212) | 1.85340701 |
| 109 | Venous insufficiency (HP:0005293) | 1.85138854 |
| 110 | Inguinal hernia (HP:0000023) | 1.83553115 |
| 111 | Flat cornea (HP:0007720) | 1.83187974 |
| 112 | Obstructive sleep apnea (HP:0002870) | 1.83007753 |
| 113 | Supraventricular tachycardia (HP:0004755) | 1.82960388 |
| 114 | Limited hip movement (HP:0008800) | 1.82480173 |
| 115 | Natal tooth (HP:0000695) | 1.81548616 |
| 116 | Protruding ear (HP:0000411) | 1.81365749 |
| 117 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.81267269 |
| 118 | Hypoplasia of the iris (HP:0007676) | 1.80262601 |
| 119 | Spondylolisthesis (HP:0003302) | 1.79389539 |
| 120 | Bundle branch block (HP:0011710) | 1.78243406 |
| 121 | Hypoplastic ischia (HP:0003175) | 1.78072248 |
| 122 | Disproportionate tall stature (HP:0001519) | 1.77043767 |
| 123 | Deviation of the hallux (HP:0010051) | 1.76330494 |
| 124 | Pulmonary artery stenosis (HP:0004415) | 1.75359410 |
| 125 | Myotonia (HP:0002486) | 1.75266119 |
| 126 | Osteoarthritis (HP:0002758) | 1.75050019 |
| 127 | Thoracolumbar scoliosis (HP:0002944) | 1.74808513 |
| 128 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.74588776 |
| 129 | Mitral regurgitation (HP:0001653) | 1.73843553 |
| 130 | Elbow flexion contracture (HP:0002987) | 1.73798530 |
| 131 | Narrow nasal bridge (HP:0000446) | 1.73660056 |
| 132 | Generalized amyotrophy (HP:0003700) | 1.73298752 |
| 133 | Tarsal synostosis (HP:0008368) | 1.72636591 |
| 134 | Coxa vara (HP:0002812) | 1.72236954 |
| 135 | Flared iliac wings (HP:0002869) | 1.72234348 |
| 136 | Limb-girdle muscle weakness (HP:0003325) | 1.71673460 |
| 137 | Ulnar deviation of the wrist (HP:0003049) | 1.71135769 |
| 138 | Abnormality of skull ossification (HP:0002703) | 1.70778306 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.04889385 |
| 2 | TTN | 3.96829312 |
| 3 | SIK1 | 3.37996186 |
| 4 | ERN1 | 3.03996812 |
| 5 | KIT | 2.65947989 |
| 6 | CAMK1D | 2.60303110 |
| 7 | LATS1 | 2.58769946 |
| 8 | LMTK2 | 2.58044290 |
| 9 | RIPK1 | 2.56108534 |
| 10 | DDR2 | 2.49579356 |
| 11 | PDGFRA | 2.39771387 |
| 12 | BCKDK | 2.38025908 |
| 13 | MYLK | 2.37093292 |
| 14 | INSRR | 2.16756353 |
| 15 | PRKD3 | 2.11037288 |
| 16 | CAMK1G | 2.09926478 |
| 17 | TESK1 | 1.97600213 |
| 18 | DMPK | 1.94413095 |
| 19 | GRK1 | 1.91994068 |
| 20 | PHKG1 | 1.87265043 |
| 21 | PHKG2 | 1.87265043 |
| 22 | LATS2 | 1.82403141 |
| 23 | PDK3 | 1.81675650 |
| 24 | PDK4 | 1.81675650 |
| 25 | GRK5 | 1.80934581 |
| 26 | OBSCN | 1.80375976 |
| 27 | EPHB2 | 1.75691651 |
| 28 | PIK3CA | 1.71302994 |
| 29 | FRK | 1.63624538 |
| 30 | EPHA3 | 1.55200623 |
| 31 | TGFBR2 | 1.52173133 |
| 32 | FER | 1.46858633 |
| 33 | PKN2 | 1.46448355 |
| 34 | ADRBK1 | 1.43680005 |
| 35 | STK38L | 1.40939725 |
| 36 | MST1R | 1.34486060 |
| 37 | MAPK7 | 1.30936087 |
| 38 | ADRBK2 | 1.25700429 |
| 39 | LIMK1 | 1.23684368 |
| 40 | ABL2 | 1.23436191 |
| 41 | TIE1 | 1.23214782 |
| 42 | GRK7 | 1.22937665 |
| 43 | PDK2 | 1.11379427 |
| 44 | FGFR4 | 1.09527083 |
| 45 | PRKAA2 | 1.08827476 |
| 46 | PAK3 | 1.03855260 |
| 47 | PRKCH | 1.03456440 |
| 48 | EPHB1 | 1.02085687 |
| 49 | PRKD2 | 0.97166962 |
| 50 | PRKD1 | 0.96572880 |
| 51 | MAPKAPK3 | 0.96472127 |
| 52 | PTK6 | 0.95525936 |
| 53 | MET | 0.91128297 |
| 54 | JAK1 | 0.87862117 |
| 55 | PIK3CG | 0.85831352 |
| 56 | MAP3K3 | 0.85050543 |
| 57 | MAP3K7 | 0.83904190 |
| 58 | PTK2 | 0.83161385 |
| 59 | PAK2 | 0.83054199 |
| 60 | RPS6KC1 | 0.82866217 |
| 61 | RPS6KL1 | 0.82866217 |
| 62 | FGFR3 | 0.82338190 |
| 63 | PINK1 | 0.81275581 |
| 64 | CDC42BPA | 0.80927243 |
| 65 | MOS | 0.80300665 |
| 66 | STK38 | 0.77201295 |
| 67 | PDGFRB | 0.75330365 |
| 68 | MTOR | 0.74881260 |
| 69 | PRKAA1 | 0.73543628 |
| 70 | WNK4 | 0.73253963 |
| 71 | GRK6 | 0.72051035 |
| 72 | WNK1 | 0.70352774 |
| 73 | RPS6KA6 | 0.70329825 |
| 74 | ROCK1 | 0.68900735 |
| 75 | FGFR2 | 0.67852030 |
| 76 | MAP3K2 | 0.66414739 |
| 77 | MAP2K1 | 0.65684521 |
| 78 | PTK2B | 0.63730774 |
| 79 | MAPK4 | 0.63555929 |
| 80 | BMX | 0.59397309 |
| 81 | EEF2K | 0.58893051 |
| 82 | ROCK2 | 0.58056418 |
| 83 | AKT3 | 0.56365839 |
| 84 | TGFBR1 | 0.56225527 |
| 85 | HIPK2 | 0.56194187 |
| 86 | CAMK2G | 0.54640429 |
| 87 | IRAK1 | 0.54329884 |
| 88 | ILK | 0.52816298 |
| 89 | MAP2K3 | 0.51644432 |
| 90 | MARK2 | 0.49848546 |
| 91 | TYK2 | 0.49076856 |
| 92 | NEK9 | 0.48548245 |
| 93 | SGK3 | 0.48131000 |
| 94 | GSK3A | 0.47962433 |
| 95 | CAMK4 | 0.46161301 |
| 96 | RET | 0.46102645 |
| 97 | TBK1 | 0.45801900 |
| 98 | STK3 | 0.45759988 |
| 99 | IRAK3 | 0.45034305 |
| 100 | ZAK | 0.43809261 |
| 101 | PRKCE | 0.43319245 |
| 102 | FLT3 | 0.43076609 |
| 103 | MARK1 | 0.41671270 |
| 104 | CAMK1 | 0.41101550 |
| 105 | PAK1 | 0.39252392 |
| 106 | PRKG2 | 0.39201447 |
| 107 | NLK | 0.37518872 |
| 108 | FGFR1 | 0.37160488 |
| 109 | PIM2 | 0.37056051 |
| 110 | NEK2 | 0.36958171 |
| 111 | RPS6KA2 | 0.36425002 |
| 112 | MAPK12 | 0.36391947 |
| 113 | PDPK1 | 0.36347481 |
| 114 | MAPK11 | 0.35774961 |
| 115 | ARAF | 0.35561288 |
| 116 | MAPK15 | 0.35470509 |
| 117 | ZAP70 | 0.34953465 |
| 118 | TRPM7 | 0.34222208 |
| 119 | MAPKAPK2 | 0.34003248 |
| 120 | DAPK3 | 0.33976738 |
| 121 | ICK | 0.33450311 |
| 122 | ERBB4 | 0.32973146 |
| 123 | JAK2 | 0.32493629 |
| 124 | PAK4 | 0.31499101 |
| 125 | PRKACG | 0.31436713 |
| 126 | CSK | 0.30397828 |
| 127 | JAK3 | 0.29955617 |
| 128 | DYRK1B | 0.29180276 |
| 129 | PRKG1 | 0.28948533 |
| 130 | SRC | 0.27053319 |
| 131 | MAP3K6 | 0.26370343 |
| 132 | INSR | 0.26233585 |
| 133 | CDK6 | 0.24305011 |
| 134 | NTRK1 | 0.23363906 |
| 135 | TAOK1 | 0.23185833 |
| 136 | SGK2 | 0.22560743 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.03185069 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.74517248 |
| 3 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.74486507 |
| 4 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.54426593 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.51640955 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49421686 |
| 7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.24684491 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.20740733 |
| 9 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.18056454 |
| 10 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.03456352 |
| 11 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.91260325 |
| 12 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.86051646 |
| 13 | Focal adhesion_Homo sapiens_hsa04510 | 1.73741333 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.58193463 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.57595010 |
| 16 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.56046893 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.52195172 |
| 18 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.49630243 |
| 19 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.48800334 |
| 20 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.48682855 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46356430 |
| 22 | Insulin resistance_Homo sapiens_hsa04931 | 1.43823975 |
| 23 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.42394628 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.35991712 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.26148955 |
| 26 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.25815885 |
| 27 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.25241359 |
| 28 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.22186057 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13884670 |
| 30 | Lysine degradation_Homo sapiens_hsa00310 | 1.13040742 |
| 31 | Amoebiasis_Homo sapiens_hsa05146 | 1.10502955 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 1.09785923 |
| 33 | Melanogenesis_Homo sapiens_hsa04916 | 1.08979071 |
| 34 | Peroxisome_Homo sapiens_hsa04146 | 1.08381811 |
| 35 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.06473813 |
| 36 | Gap junction_Homo sapiens_hsa04540 | 1.03751213 |
| 37 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03492347 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03043773 |
| 39 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.00598807 |
| 40 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.95805927 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.94957485 |
| 42 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.93899632 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.93340069 |
| 44 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.92559480 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.91958917 |
| 46 | Axon guidance_Homo sapiens_hsa04360 | 0.91831130 |
| 47 | Pathways in cancer_Homo sapiens_hsa05200 | 0.91777360 |
| 48 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.91090738 |
| 49 | Galactose metabolism_Homo sapiens_hsa00052 | 0.88292891 |
| 50 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.87716870 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 0.86314014 |
| 52 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.86183060 |
| 53 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.86110140 |
| 54 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.85863355 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85625735 |
| 56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.84502486 |
| 57 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.83764799 |
| 58 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.83243416 |
| 59 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.82622011 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.82472298 |
| 61 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.81502823 |
| 62 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.80973470 |
| 63 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.79592150 |
| 64 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.78411945 |
| 65 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.78373613 |
| 66 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76922323 |
| 67 | Bladder cancer_Homo sapiens_hsa05219 | 0.75860221 |
| 68 | Adherens junction_Homo sapiens_hsa04520 | 0.75343227 |
| 69 | Prostate cancer_Homo sapiens_hsa05215 | 0.75081348 |
| 70 | Cocaine addiction_Homo sapiens_hsa05030 | 0.74578593 |
| 71 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.74548520 |
| 72 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.74335013 |
| 73 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73795431 |
| 74 | Bile secretion_Homo sapiens_hsa04976 | 0.73363485 |
| 75 | Malaria_Homo sapiens_hsa05144 | 0.72564187 |
| 76 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.72283532 |
| 77 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.70750676 |
| 78 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68930164 |
| 79 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.67998179 |
| 80 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.67616446 |
| 81 | Tight junction_Homo sapiens_hsa04530 | 0.67108700 |
| 82 | Phagosome_Homo sapiens_hsa04145 | 0.66749657 |
| 83 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.65530148 |
| 84 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.65517172 |
| 85 | ABC transporters_Homo sapiens_hsa02010 | 0.65229968 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64951395 |
| 87 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.64878237 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64771217 |
| 89 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.64701638 |
| 90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63865298 |
| 91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62192053 |
| 92 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.61496076 |
| 93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60133896 |
| 94 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.59659398 |
| 95 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.58539361 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.58348791 |
| 97 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.57696439 |
| 98 | Glioma_Homo sapiens_hsa05214 | 0.56741901 |
| 99 | Histidine metabolism_Homo sapiens_hsa00340 | 0.56666972 |
| 100 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.56628732 |
| 101 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56070798 |
| 102 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55371429 |
| 103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.55197919 |
| 104 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.55109237 |
| 105 | Renin secretion_Homo sapiens_hsa04924 | 0.54421175 |
| 106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.53631706 |
| 107 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.53414958 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53257533 |
| 109 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53015485 |
| 110 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.52532557 |
| 111 | Melanoma_Homo sapiens_hsa05218 | 0.52419711 |
| 112 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.52284147 |
| 113 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52105721 |
| 114 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.51780374 |
| 115 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.50967900 |
| 116 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.50395947 |
| 117 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.49560737 |
| 118 | Endocytosis_Homo sapiens_hsa04144 | 0.47446739 |
| 119 | Viral myocarditis_Homo sapiens_hsa05416 | 0.47345330 |
| 120 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.46827802 |
| 121 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46673723 |
| 122 | Lysosome_Homo sapiens_hsa04142 | 0.46299043 |
| 123 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45995030 |
| 124 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.45898342 |
| 125 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.45031125 |
| 126 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44985582 |
| 127 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.44133964 |
| 128 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44006108 |
| 129 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43793094 |
| 130 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43558179 |
| 131 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.43418820 |
| 132 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43059654 |
| 133 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42675298 |
| 134 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42497006 |
| 135 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.41642312 |
| 136 | Other glycan degradation_Homo sapiens_hsa00511 | 0.40092857 |
| 137 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.39813132 |
| 138 | Insulin secretion_Homo sapiens_hsa04911 | 0.39145467 |
| 139 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.38918337 |
| 140 | Prion diseases_Homo sapiens_hsa05020 | 0.38321848 |
| 141 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38168929 |
| 142 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.37752032 |
| 143 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.37135666 |
| 144 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36524601 |
| 145 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.36249751 |
| 146 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.36070081 |
| 147 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34836908 |
| 148 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.34620309 |
| 149 | Mineral absorption_Homo sapiens_hsa04978 | 0.33639014 |

